VIA Global Health has a world class e-commerce procurement and distribution platform to serve low-and middle-income countries with life-saving medical technologies, with the goal of universal access to critical medical products, information, services, and life-saving medical equipment to underserved communities. The company has received support from the Bill and Melinda Gates Foundation to support its efforts in expanding distribution of maternal and newborn health products. By providing a link to smaller distributors in low- and middle-income countries, products can reach parts of the world that usually are not included in companies' launch plans. VIA Global Health has delivered products to over 70 countries and offers a number of important products for maternal and child care as well as COVID-19-related products.
"Calmark's products for newborn infants fit very well within our product portfolio; point of care solutions like those developed by Calmark are in great need in countries where the health care systems are resource constrained. The products will soon be available for global order on our website and we will support our customers with training and logistics to access these products. We very much look forward to collaborating with Calmark," says Brinnon Mandel, Vice President of Market Insights, VIA Global Health.
"VIA Global Health has a unique network in those countries where our product promises to deliver the most significant benefits. For us, this cooperation is an important step towards fulfilling our mission to reduce infant mortality before 2030. VIA Global Health is a greatly appreciated company that has received considerable attention. It has a big heart, and we are exceedingly proud to have the opportunity to work with it," says Anna Söderlund, CEO of Calmark.
Read more about VIA Global Health: https://viaglobalhealth.com/
This information is information that Calmark Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 09:25 CET on 26 November 2020.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.